These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 6454012
1. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]. Hirasawa S, Abe H, Bekki E, Hashimoto I, Sawada Y, Nakamura T, Mikami J, Watanabe Y. Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012 [Abstract] [Full Text] [Related]
2. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)]. Abe H, Hirasawa S, Bekki E, Sawada Y, Hashimoto I, Nakamura T, Mikami J, Katoh H, Matsuda S. Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172 [Abstract] [Full Text] [Related]
3. [Cefoperazone concentration in infected tissues and clinical effect for patients with peritonitis (author's transl)]. Hashimoto I, Sawada Y, Nakamura T, Mikami J, Hirasawa S, Abe H, Bekki E, Watanabe Y. Jpn J Antibiot; 1980 Dec; 33(12):1301-5. PubMed ID: 6454013 [Abstract] [Full Text] [Related]
4. [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)]. Kasai Y, Nakanishi M, Sawada Y, Nakamura T, Hashimoto I, Mikami J, Bekki E, Hirasawa S, Abe H, Kasai K, Omosu M. Jpn J Antibiot; 1981 Mar; 34(3):447-52. PubMed ID: 6270392 [Abstract] [Full Text] [Related]
5. [Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration]. Bekki E, Abe H, Sawada Y, Hashimoto I, Nakamura T, Mikami J, Kasai Y, Nakanishi M. Jpn J Antibiot; 1983 Jul; 36(7):1604-14. PubMed ID: 6317907 [Abstract] [Full Text] [Related]
6. [Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author's transl)]. Nakamura T, Hashimoto I, Sawada Y, Mikami J, Saitoh M, Hattanda K, Bekki E, Nishidai H, Nakanishi M, Kasai Y. Jpn J Antibiot; 1982 Apr; 35(4):897-908. PubMed ID: 7097987 [Abstract] [Full Text] [Related]
7. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections]. Koizumi M, Simosegawa T, Yanbe M, Goto Y, Sugawara H, Kanno Y, Kanazawa Y, Kai Y, Sato T, Endou K. Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263 [Abstract] [Full Text] [Related]
8. [Clinical studies on dibekacin for infectious diseases following intramuscular and intravenous drip administration. Concentration in infected tissues and clinical responses (author's transl)]. Nakamura T, Hashimoto I, Sawada Y, Mikami J, Bekki E, Kasai Y, Nakanishi M. Jpn J Antibiot; 1981 Jun; 34(6):980-93. PubMed ID: 7289045 [Abstract] [Full Text] [Related]
9. [Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)]. Hashimoto I, Sawada Y, Nakamura T, Mikami J, Bekki E, Hirasawa S, Abe H, Katoh H, Matsuda S. Jpn J Antibiot; 1981 Apr; 34(4):623-30. PubMed ID: 6457171 [Abstract] [Full Text] [Related]
10. [Experimental and clinical studies on cefoperazone (author's transl)]. Toyonaga Y, Kurosu Y, Yoshikawa H, Kumagai K, Takahashi T, Hori M. Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729 [Abstract] [Full Text] [Related]
11. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections]. Tanimura H, Ohnishi H, Okamura T, Uenishi M, Ichimiya G, Kobayashi Y, Aoki Y, Oka S, Yamamoto S, Shimada K. Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942 [Abstract] [Full Text] [Related]
12. [Clinical studies on cefoperazone treatment for bile duct infections (author's transl)]. Hirayama T, Kikuchi K. Jpn J Antibiot; 1981 Jun; 34(6):934-8. PubMed ID: 6457179 [Abstract] [Full Text] [Related]
13. [Studies on cefmetazole concentration in human biliary tract and clinical effect for acute or subacute cholecystitis (author's transl)]. Kasai Y, Nakanishi M, Sawada Y, Nakamura T, Hashimoto I, Mikami J, Sahashi Y. Jpn J Antibiot; 1979 May; 32(5):606-11. PubMed ID: 459087 [No Abstract] [Full Text] [Related]
14. [Cefoperazone in the treatment of infections of the gallbladder, biliary ducts and liver in surgical patients]. Vyhnánek F, Lochman O, Pelák Z. Rozhl Chir; 1996 Nov; 75(11):544-8. PubMed ID: 9072836 [Abstract] [Full Text] [Related]
16. [Clinical studies on gentamicin for infectious diseases following intravenous drip infusion]. Nakamura T, Hashimoto I, Sawada Y, Mikami J, Saitoh M, Hattanda K, Bekki E, Nishindai H, Nakanishi M, Kasai Y, Deguchi K. Jpn J Antibiot; 1983 Jan; 36(1):55-70. PubMed ID: 6842828 [Abstract] [Full Text] [Related]
18. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation]. Shima K, Ueno K, Ooto T, Shima Y, Miyata T, Sei T, Yonemura Y, Uemura T, Takano N. Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387 [Abstract] [Full Text] [Related]
19. [Laboratory and clinical studies on cefoperazone in pediatrics treatment (author's transl)]. Motohiro T, Takechi T, Soejima N, Watari H, Oohashi K, Sakata Y, Nishiyama T, Ezaki Y, Yokoyama T, Nakajima T, Komatsu Y, Ishimoto K, Tominaga K, Yamashita F, Takeya S, Yamamoto M, Ohkita R, Iriki T. Jpn J Antibiot; 1980 Sep; 33(9):943-58. PubMed ID: 6452544 [Abstract] [Full Text] [Related]
20. [Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections]. Shinagawa N, Takeda S, Oohira S, Yasuda Y, Fujisaki M, Saito H, Ueda M, Mitamura K, Nishio T, Itakura M, Koyama M, Hirano M, Ohyama R, Kako M, Amako Y, Okuda K, Iwasa T, Sugiyama A, Hirano M, Takashima S, Ohswawa N, Nakaya S, Yamada M, Zeze F, Ishii J. Jpn J Antibiot; 1997 Nov; 50(11):862-70. PubMed ID: 9651604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]